Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.
Jamal R, Lapointe R, Cocolakis E, Thébault P, Kazemi S, Friedmann JE, Dionne J, Cailhier JF, Bélanger K, Ayoub JP, Le H, Lambert C, El-Hajjar J, van Kempen LC, Spatz A, Miller WH Jr. Jamal R, et al. Among authors: van kempen lc. J Immunother Cancer. 2017 Nov 21;5(1):83. doi: 10.1186/s40425-017-0290-x. J Immunother Cancer. 2017. PMID: 29157311 Free PMC article. Clinical Trial.
The biology of melanoma prognostic factors.
Spatz A, Stock N, Batist G, van Kempen LC. Spatz A, et al. Among authors: van kempen lc. Discov Med. 2010 Jul;10(50):87-93. Discov Med. 2010. PMID: 20670603 Free article. Review.
The dual role of the X-linked FoxP3 gene in human cancers.
Redpath M, Xu B, van Kempen LC, Spatz A. Redpath M, et al. Among authors: van kempen lc. Mol Oncol. 2011 Apr;5(2):156-63. doi: 10.1016/j.molonc.2011.03.001. Epub 2011 Mar 30. Mol Oncol. 2011. PMID: 21489891 Free PMC article. Review.
Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.
van Kempen LC, van den Hurk K, Lazar V, Michiels S, Winnepenninckx V, Stas M, Spatz A, van den Oord JJ. van Kempen LC, et al. Among authors: van den oord jj, van den hurk k. Virchows Arch. 2012 Oct;461(4):441-8. doi: 10.1007/s00428-012-1309-9. Epub 2012 Sep 6. Virchows Arch. 2012. PMID: 22956368
Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.
van Kempen LC, Wang H, Aguirre ML, Spatz A, Kasymjanova G, Vilacha JF, Groves MR, Agulnik J, Small D. van Kempen LC, et al. J Thorac Oncol. 2018 Sep;13(9):e161-e163. doi: 10.1016/j.jtho.2018.04.020. Epub 2018 Apr 25. J Thorac Oncol. 2018. PMID: 29704676 Free article. No abstract available.
Molecular pathology of cutaneous melanoma.
van Kempen LC, Redpath M, Robert C, Spatz A. van Kempen LC, et al. Melanoma Manag. 2014 Nov;1(2):151-164. doi: 10.2217/mmt.14.23. Epub 2014 Dec 4. Melanoma Manag. 2014. PMID: 30190820 Free PMC article. Review.
Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
Ezer N, Wang H, Corredor AG, Fiset PO, Baig A, van Kempen LC, Chong G, Issac MSM, Fraser R, Spatz A, Riviere JB, Broët P, Spicer J, Camilleri-Broët S. Ezer N, et al. Among authors: van kempen lc. Cancer Treat Res Commun. 2021;29:100484. doi: 10.1016/j.ctarc.2021.100484. Epub 2021 Oct 29. Cancer Treat Res Commun. 2021. PMID: 34773797 Free article.
121 results